Stay updated on 3.0mg Liraglutide for Weight Regain after Gastric Bypass Clinical Trial
Sign up to get notified when there's something new on the 3.0mg Liraglutide for Weight Regain after Gastric Bypass Clinical Trial page.

Latest updates to the 3.0mg Liraglutide for Weight Regain after Gastric Bypass Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedLocations section now lists New York as a study site. The page revision is updated to v3.3.3, and the old 'New York Locations' entry and 'HHS Vulnerability Disclosure' link were removed.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page now shows Revision: v3.3.2 in the revision history, replacing v3.3.1, with no changes to study content or metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page shows a new revision version (v3.3.1) replacing the prior v3.2.0 in the study record. This is a version history update and does not alter the study content.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page no longer displays a general government funding/operating status banner, a non-content notice that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange DetectedThe new screenshot shows updates to study record dates and posted results notes, while core study details, eligibility criteria, and design remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check96 days agoChange DetectedUpdate adds a government-operating-status notice and updates version to v3.2.0, replacing the previous v3.1.0.SummaryDifference5%

Stay in the know with updates to 3.0mg Liraglutide for Weight Regain after Gastric Bypass Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 3.0mg Liraglutide for Weight Regain after Gastric Bypass Clinical Trial page.